99m Tc-labeled rHuEpo for imaging of the erythropoietin receptor in tumors.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of labelled compounds & radiopharmaceuticals

• Publication date

  2018-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jlcr.3586PMID 29140573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease

  2016cited by this paper
• Erythropoietin Stimulates Tumor Growth via EphB4.

  2015cited by this paper
• Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction

  2014cited by this paper
• Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience

  2014cited by this paper
• Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma

  2013cited by this paper
• Progress in detecting cell-surface protein receptors: the erythropoietin receptor example

  2013cited by this paper
• The effect of erythropoietin on normal and neoplastic cells

  2012cited by this paper
• Targeted Near-Infrared Imaging of the Erythropoietin Receptor in Human Lung Cancer Xenografts

  2012cited by this paper
• 99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers.

  2011cited by this paper
• Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma.

  2011cited by this paper
• Erythropoietin Receptor Contributes to Melanoma Cell Survival in vivo

  2011cited by this paper
• The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression

  2011cited by this paper
• Erythropoietin and Tumor Angiogenesis

  2010cited by this paper
• Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact

  2010cited by this paper
• Use of erythropoietin-stimulating agents in breast cancer patients: a risk review.

  2009cited by this paper
• Erythropoietin in cancer: an update.

  2008cited by this paper
• Preparation and biodistribution of [111In]-rHuEpo for erythropoietin receptor imaging

  2008cited by this paper
• The erythropoietin receptor in normal and cancer tissues.

  2008cited by this paper
• Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia.

  2007cited by this paper
• Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

  2006cited by this paper
• Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.

  2005cited by this paper
• The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin

  2005cited by this paper
• The erythropoietin receptor and its expression in tumor cells and other tissues.

  2004cited by this paper

• No citing papers are available for this paper.